Motley Fool Asset Management LLC Acquires 5,363 Shares of HCA Healthcare, Inc. $HCA

Motley Fool Asset Management LLC increased its holdings in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 27.4% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 24,971 shares of the company’s stock after purchasing an additional 5,363 shares during the quarter. Motley Fool Asset Management LLC’s holdings in HCA Healthcare were worth $11,658,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. MJP Associates Inc. ADV raised its stake in HCA Healthcare by 2.9% in the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after buying an additional 21 shares in the last quarter. Cary Street Partners Investment Advisory LLC increased its position in shares of HCA Healthcare by 7.5% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after purchasing an additional 21 shares in the last quarter. Centerpoint Advisors LLC boosted its position in shares of HCA Healthcare by 11.0% in the 3rd quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock worth $95,000 after purchasing an additional 22 shares in the last quarter. Cary Street Partners Financial LLC boosted its position in shares of HCA Healthcare by 3.9% in the 3rd quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock worth $251,000 after purchasing an additional 22 shares in the last quarter. Finally, Plato Investment Management Ltd boosted its holdings in HCA Healthcare by 0.6% in the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after acquiring an additional 22 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

HCA Healthcare Stock Performance

NYSE:HCA opened at $374.01 on Wednesday. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52. The firm has a market cap of $82.97 billion, a price-to-earnings ratio of 12.86, a PEG ratio of 1.15 and a beta of 1.12. The firm’s fifty day moving average is $435.15 and its two-hundred day moving average is $475.62.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. During the same period in the previous year, the company posted $6.45 earnings per share. HCA Healthcare’s revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on HCA shares. Truist Financial set a $413.00 price target on HCA Healthcare in a report on Thursday, June 4th. Weiss Ratings downgraded HCA Healthcare from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, May 18th. Stephens dropped their price objective on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. UBS Group boosted their price objective on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a report on Monday, February 23rd. Finally, KeyCorp dropped their price objective on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $506.14.

View Our Latest Analysis on HCA

About HCA Healthcare

(Free Report)

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.